• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers".

作者信息

Carlson Josh J, Gries Katie, Yeung Kai, Sullivan Sean D, Garrison Louis P

机构信息

Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA,

出版信息

Appl Health Econ Health Policy. 2014 Oct;12(5):567-8. doi: 10.1007/s40258-014-0119-4.

DOI:10.1007/s40258-014-0119-4
PMID:25124263
Abstract
摘要

相似文献

1
Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers".作者对库尔托和加拉蒂尼的回复：“医疗保健支付方与医疗产品制造商之间基于绩效的风险分担安排的现状与趋势”
Appl Health Econ Health Policy. 2014 Oct;12(5):567-8. doi: 10.1007/s40258-014-0119-4.
2
Comment on: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers".对《医疗保健支付方与医疗产品制造商之间基于绩效的风险分担安排的现状与趋势》的评论
Appl Health Econ Health Policy. 2014 Oct;12(5):565. doi: 10.1007/s40258-014-0118-5.
3
Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers.医疗保健支付方与医疗产品制造商之间基于绩效的风险分担安排的现状与趋势
Appl Health Econ Health Policy. 2014 Jun;12(3):231-8. doi: 10.1007/s40258-014-0093-x.
4
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.基于绩效的风险分担安排——设计、实施和评估的良好实践：ISPOR 基于绩效的风险分担安排良好实践工作组的报告。
Value Health. 2013 Jul-Aug;16(5):703-19. doi: 10.1016/j.jval.2013.04.011. Epub 2013 Jul 19.
5
Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.美国私营部门风险分担协议：趋势、障碍与前景
Am J Manag Care. 2015 Sep;21(9):632-40.
6
Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement.事实证明，将药品支付与健康结果挂钩的风险分担安排很难实施。
Health Aff (Millwood). 2011 Dec;30(12):2329-37. doi: 10.1377/hlthaff.2010.1147.
7
Emerging roles for pharmacists in performance-based risk-sharing arrangements.药剂师在基于绩效的风险分担安排中的新角色。
Am J Health Syst Pharm. 2017 Jul 1;74(13):1007-1012. doi: 10.2146/ajhp160398. Epub 2017 May 18.
8
When do performance-based risk-sharing arrangements make sense?基于绩效的风险分担安排何时才有意义？
Eur J Health Econ. 2015 Jul;16(6):569-71. doi: 10.1007/s10198-015-0683-z.
9
Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.无法获得满足感？付费绩效能否有所帮助？：理解创新型医疗产品基于绩效的风险分担协议的经济框架。
Pharmacoeconomics. 2010;28(2):93-102. doi: 10.2165/11314080-000000000-00000.
10
Performance-based risk-sharing arrangements for devices and diagnostics in the United States: a systematic review.美国医疗器械和诊断试剂的基于绩效的风险分担安排：系统评价。
J Manag Care Spec Pharm. 2022 Jan;28(1):78-83. doi: 10.18553/jmcp.2022.28.1.78.